| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.28 | 0.07 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |